Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for MiNK Therapeutics, Inc. (INKT), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-4.44
P/B ratioShare price divided by book value per share.
-3.80
P/S ratioMarket value divided by annual revenue.
0.00
PEG ratioP/E divided by the earnings growth rate.
-0.26
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-3.79
EV / RevenueEnterprise value against annual revenue.
0.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-23.09%
Free cash flow yieldFree cash flow as a percentage of market value.
-12.60%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
0.00%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Return on equityProfit as a percentage of shareholders’ equity.
83.45%
Return on assetsProfit as a percentage of total assets.
-118.15%
Return on capital employedOperating profit against the capital the business uses.
-604.20%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.23
Quick ratioThe same, excluding inventory.
1.23
Cash ratioCash alone against current liabilities.
1.00
Debt to equityTotal borrowings against shareholders’ equity.
-0.36
Debt to assetsTotal borrowings against total assets.
0.36
Interest coverageHow many times operating profit covers the interest bill.
0.00
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-2.93
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$54.65M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$45.19M
EmployeesReported headcount.
23
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
MiNK Therapeutics, Inc. (INKT) statistics — frequently asked questions
What is MiNK Therapeutics, Inc.'s P/E ratio?
MiNK Therapeutics, Inc. (INKT) trades on a price-to-earnings ratio of -4.44. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is MiNK Therapeutics, Inc.'s return on equity?
MiNK Therapeutics, Inc. (INKT) reports a return on equity of 83.45%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does MiNK Therapeutics, Inc. carry?
MiNK Therapeutics, Inc. (INKT) has a debt-to-equity ratio of -0.36, which compares total borrowings with shareholders' equity.